Cell ReportsCancer BiologyPeer-reviewed journal article
Low abundant intestinal commensals modulate immune control of chronic myeloid leukemia stem cells
Francesca RonchiiD, Magdalena HinterbrandneriD, Viviana Rubino, Michaela Römmele, Tanja Chiorazzo, Catherine MooseriD, Stephanie Christine Ganal-VonarburgiD, Kathy D. McCoyiD, Ravi Bhatia, Andrew James MacphersoniD, Adrian F. OchsenbeiniD, Carsten RietheriD
Abstract
Leukemia stem cells (LSCs) are resistant to therapy and immune control. The reason for their resistance to elimination by cytotoxic T cells (CTLs) remains unclear. This study shows that specific low abundant Gram-negative intestinal commensals of the genus Sutterella suppress the anti-leukemia immune response in chronic myeloid leukemia (CML). We found that germ-free and specific opportunistic pathogen-free (SOPF) mice are protected from CML development and that colonization of SOPF mice with Sutterella wadsworthensis, but not other related and unrelated bacterial strains, rescues CML development. A higher prevalence of this microbe resulted in Myd88/TRIF-mediated CTL exhaustion in SPF compared to SOPF CML mice as evidenced by higher surface expression of exhaustion markers on CTLs, a reduced capacity to produce interferon-gamma and granzyme B and to kill LSCs in vitro. These findings provide new insights into the immune control of LSCs and identify Sutterella species as regulators of anti-leukemic immunity in CML.
- organism: mouse
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 4
- FWCI
- 0.96
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia
G. Boncompagni, V. Tatangelo, … C. T. Baldari·bioRxiv·Oct 23, 2023
- Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells.
Hrishi Venkatesh, Enoc Granados Centeno, … Sean I. Tracy·BloodPeer-reviewed·Sep 4, 2025
- CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia
P. Deschamps, M. Wacheux, … D. Selimoglu-Buet·bioRxiv·Mar 8, 2024
- Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
J. R. Rivas, Y. Liu, … S. Bondada·bioRxiv·Jul 15, 2020
- Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia
M. Murtadha, M. Park, … F. Pichiorri·bioRxiv·Feb 27, 2023
- Granulocyte Derived Resistin Inhibits Monocyte Maturation and Induces Immune Suppression in CMML
Nathan J. Hull, Rachel Cant, … Kiran Batta·bioRxiv·Mar 3, 2025